Suzhou Suncadia Biopharmaceuticals Co., Ltd.

This study is for people with a high-risk form of bladder cancer that has returned after standard BCG immunotherapy. It will compare a new combination treatment (SHR-1501 plus BCG) against standard chemotherapy drugs chosen by the doctor. The goal is to see if the new combination…

This early-stage clinical trial is testing a new injectable drug called SHR-4298 in patients with advanced solid tumors that have returned or spread. The main goals are to find a safe dose and see if the drug can help control the cancer. The study will enroll about 200 adults who…

This study aims to find a safe and effective dose for a new cancer drug called SHR-4375 when used alongside other cancer treatments. It is for adults with advanced solid tumors that have not responded to standard therapies. The main goals are to check for side effects and see if …

This study is testing an experimental drug called SHR-1826 for people with advanced non-small cell lung cancer that has spread or can't be removed by surgery. About 90 participants who have already tried other treatments will receive the drug through an IV every three weeks. Rese…

This study is testing whether adding two new immunotherapy drugs (adebrelimab and SHR-8068) to standard chemotherapy and radiation before surgery helps people with locally advanced rectal cancer. Researchers want to see if this combination helps shrink tumors more effectively and…

This study is testing an experimental drug called SHR-A1904 for people with advanced bile duct cancer that has spread or cannot be removed by surgery and has stopped responding to standard treatments. The drug is designed to target cancer cells that have a specific marker called …

This study is for women whose cervical cancer has returned or spread after standard chemotherapy and immunotherapy. It will compare a new drug called SHR-A2102 against standard chemotherapy to see which helps patients live longer. The main goal is to see if the new drug improves …

This is the first study in humans to test a new potential drug called SHR-1894 for skin inflammation conditions like dermatitis. Researchers will give single injections to 40 healthy volunteers to check for side effects and see how the body absorbs and processes the drug. The mai…